OncoDaily IO· @OncoDailyIO · X·· 3 天前评分70
正文 · 原文
🧬 AMPLIFY-7P: Primary DFS endpoint not met.
https://oncodaily.com/oncolibrary/immune-oncology/amplify-7p
In 144 patients with resected KRAS-mutated PDAC, camupepimut (ELI-002 7P) vs observation:
⏳ Median DFS: 23.8 vs 21.2 months
📊 HR 0.85; P=0.5329
No significant DFS improvement.
#ESMO2026 #OncoDaily #ESMO26
109 浏览 · 1 赞 · 0 转发 · 0 回复
会议摘要
7P按 Proffered paper 1: Gastrointestinal tumour, upper digestive 对上
Proffered paper 1: Gastrointestinal tumour, upper digestive
https://esmocongress.esmo.org来源：OncoDaily IO · x.com